Opinion Article by Chris Scarisbrick, Deputy Managing Director, Sectra.Now, a tsunami is set to follow, with projects involving vast amounts of data needed for the care of millions of patients, soon to become commonplace.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the successful nationwide rollout of its ambulatory cardiac monitoring service in Spain using its unique wearable ePatch paired with its AI-driven Cardiologs analytics platform. 14 Spanish healthcare providers across the country are now using the company's ePatch extended wear Holter monitors to detect life-threatening heart arrhythmias such as atrial fibrillation (AF).
Opinion Article by Dr. Paul Deffley, Chief Medical Officer, Alcidion.Recent research from Newsweek and Statista, which ranked the world’s top 'smart hospitals', placed its first NHS trust at position 72 on the list.
The new tool improves on existing risk assessment tools for heart failure by harnessing the power of machine learning (ML) and artificial intelligence (AI) to determine patient-specific risks of developing unfavorable outcomes with heart failure.
Challenges include questions about data privacy and algorithmic bias, how we can make sure that AI tools are subject to robust validation and testing processes, and how to make sure they are used safely in a clinical setting.